A Kentucky man recently filed a new EzriCare class action lawsuit in the U.S. District Court for the Eastern District of Kentucky. He seeks compensation for himself and all others similarly situated who purchased EzriCare and Delsam Pharma Artificial Tear products without knowing that they…
An Arizona woman recently filed a new Tepezza lawsuit in the U.S. District Court for the Northern District of Illinois. She claims that after taking Tepezza, she suffered from serious injuries. She seeks compensatory and punitive damages. Plaintiff Claims Tepezza Caused Her to Suffer from…
A Florida man and his wife recently filed a new Zantac lawsuit in the U.S. District Court for the Southern District of Florida. He claims that after taking Zantac (ranitidine) for several years, he suffered serious injuries and blames current and former Zantac manufacturers, including…
The Centers for Disease Control and Prevention (CDC) reports that each year at least two million people become infected with antibiotic-resistant bacteria in the United States, and that at least 23,000 of them die from these infections. Antibiotics are designed to kill or stop the…
On November 12, 2015, a Louisiana resident filed a new Xarelto lawsuit in the Eastern District of Louisiana, the current location of the consolidated Xarelto MultiDistrict Litigation (“MDL”). The plaintiff blames Xarelto for her grandmother’s death, and seeks in excess of $75,000 in damages from…
On October 5, 2015, a husband and wife from Morrow County, Ohio, filed a new Xarelto lawsuit in the U.S. District Court for the Southern District of Ohio. They allege that manufacturers Janssen Pharmaceuticals, parent company Johnson & Johnson, and Bayer AG are liable for…
In December 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federal Xarelto lawsuits into one court in the Eastern District of Louisiana. Since then, all product liability complaints concerning Xarelto (rivaroxaban) filed in federal court have been transferred to Louisiana for pre-trial…
Janssen Pharmaceuticals and parent company, Johnson & Johnson, have been named as defendants in a number of lawsuits concerning the anti-psychotic drug, Risperdal (risperidone). Plaintiffs claim the companies failed to provide adequate warnings about serious side effects like abnormal breast growth in boys and type…
A number of lawsuits have been filed against Risperdal manufacturer Janssen Pharmaceuticals and parent company Johnson & Johnson (J&J). Plaintiffs claim that the drug companies failed to provide adequate warnings about the risks of the anti-psychotic medication, including its potential to cause gynecomastia (abnormal breast…
